Endothelial nitric oxide and 15-lipoxygenase-1 metabolites independently mediate relaxation of the rabbit aorta

Vascular Pharmacology

Volumn 56, Issue 1-2, 2012, Pages 106-112

  Aggarwal, Nitin T ^a   Gauthier, Kathryn M ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

15 Lipoxygenase; Arachidonic acid; Nitric oxide; Vascular relaxation

Indexed keywords

11,12,15 TRIHYDROXYEICOSATRIENOIC ACID; 15 HYDROXY 11,12 EPOXYEICOSATRIENOIC ACID; 15 LIPOXYGENASE 1; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; ARACHIDONIC ACID; GUANYLATE CYCLASE INHIBITOR; ICOSATRIENOIC ACID; INDOMETACIN; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PENTETIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTERY TONE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ALKENES; ANIMALS; AORTA; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; INDOMETHACIN; LIPOXYGENASE INHIBITORS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RABBITS; VASODILATION;

EID: 84856248039     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.12.002     Document Type: Article

References (51)

1. Aggarwal N.T., Holmes B.B., Cui L., Viita H., Yla-Herttuala S., Campbell W.B. Adenoviral expression of 15-lipoxygenase-1 in rabbit aortic endothelium: role in arachidonic acid-induced relaxation. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1033-H1041.
2. Aggarwal N.T., Chawengsub Y., Gauthier K.M., Viita H., Yla-Herttuala S., Campbell W.B. Endothelial 15-lipoxygenase-1 overexpression increases acetylcholine-induced hypotension and vasorelaxation in rabbits. Hypertension 2008, 51:246-251.
3. Aggarwal N.T., Gauthier K.M., Campbell W.B. 15-Lipoxygenase metabolites contribute to age-related reduction in acetylcholine-induced hypotension in rabbits. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H89-H96.
4. Aggarwal N.T., Pfister S.L., Campbell W.B. Hypercholesterolemia enhances 15-lipoxygenase-mediated vasorelaxation and acetylcholine-induced hypotension. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2209-2215.
5. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996, 94:3341-3347.
6. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 2002, 23:374-380.
7. Campbell W.B., Falck J.R. Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 2007, 49:590-596.
8. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 1996, 78:415-423.
9. Campbell W.B., Spitzbarth N., Gauthier K.M., Pfister S.L. 11,12,15-Trihydroxyeicosatrienoic acid mediates acetylcholine-induced relaxations in the rabbit aorta. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2648-H2656.
10. Chauhan S.D., Nilsson H., Ahluwalia A., Hobbs A.J. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1426-1431.
11. Chawengsub Y., Aggarwal N.T., Nithipatikom K., Gauthier K.M., Anjaiah S., Hammock B.D., Falck J.R., Campbell W.B. Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1348-H1356.
12. Chawengsub Y., Gauthier K.M., Campbell W.B. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H495-H507.
13. Cohen R.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 1995, 92:3337-3349.
14. Collins C., Tzima E. Hemodynamic forces in endothelial dysfunction and vascular aging. Exp. Gerontol. 2011, 46:185-188.
15. Czubowicz K., Czapski G.A., Cieslik M., Strosznajder R.P. Lipoxygenase inhibitors protect brain cortex macromolecules against oxidation evoked by nitrosative stress. Folia Neuropathol. 2010, 48:283-292.
16. Desai K.M., Gopalakrishnan V., Hiebert L.M., McNeill J.R., Wilson T.W. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats. Eur. J. Pharmacol. 2006, 546:120-126.
17. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998, 396:269-272.
18. Feletou M., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol. 1996, 23:1082-1090.
19. Feletou M., Tang E.H., Vanhoutte P.M. Nitric oxide the gatekeeper of endothelial vasomotor control. Front. Biosci. 2008, 13:4198-4217.
20. Feron O., Dessy C., Moniotte S., Desager J.P., Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 1999, 103:897-905.
21. + currents mediate arachidonic acid-induced relaxations of rabbit aorta. Hypertension 2004, 43:413-419.
22. Handy D.E., Loscalzo J. Nitric oxide and posttranslational modification of the vascular proteome: S-nitrosation of reactive thiols. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1207-1214.
23. Hiltunen T., Luoma J., Nikkari T., Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 1995, 92:3297-3303.
24. Holzhutter H.G., Wiesner R., Rathmann J., Stosser R., Kuhn H. A kinetic model for the interaction of nitric oxide with a mammalian lipoxygenase. Eur. J. Biochem. 1997, 245:608-616.
25. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:9265-9269.
26. Institute of Laboratory Animal Research, Commission on Life Sciences, and National Research Council., 1996. Guide for the Care and Use of Laboratory Animals: The National Academies Press.
27. Kohler R., Hoyer J. The endothelium-derived hyperpolarizing factor: insights from genetic animal models. Kidney Int. 2007, 72:145-150.
28. Korhonen R., Lahti A., Kankaanranta H., Moilanen E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4:471-479.
29. Kuhn H., Thiele B.J. Arachidonate 15-lipoxygenase. J. Lipid Mediat. Cell Signal. 1995, 12:157-170.
30. Mannick J.B., Schonhoff C.M. Nitrosylation: the next phosphorylation?. Arch. Biochem. Biophys. 2002, 408:1-6.
31. Moore S.A., Prokuski L.J., Figard P.H., Spector A.A., Hart M.N. Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. J. Cell. Physiol. 1988, 137:75-85.
32. Nakagawa T., Tanabe K., Croker B.P., Johnson R.J., Grant M.B., Kosugi T., Li Q. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat. Rev. Nephrol. 2011, 7:36-44.
33. Oliver J.J., Eppel G.A., Rajapakse N.W., Evans R.G. Lipoxygenase and cyclo-oxygenase products in the control of regional kidney blood flow in rabbits. Clin. Exp. Pharmacol. Physiol. 2003, 30:812-819.
34. Olson L.J., Knych E.T., Herzig T.C., Drewett J.G. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension 1997, 29:254-261.
35. Palomba L., Cerioni L., Cantoni O. Arachidonic acid inhibits neuronal nitric oxide synthase elicited by proinflammatory stimuli and promotes astrocyte survival with both exogenous and endogenous peroxynitrite via different mechanisms. J. Neurosci. Res. 2010, 88:2459-2468.
36. Pfister S.L., Campbell W.B. Arachidonic acid- and acetylcholine-induced relaxations of rabbit aorta. Hypertension 1992, 20:682-689.
37. Pfister S.L., Spitzbarth N., Nithipatikom K., Edgemond W.S., Falck J.R., Campbell W.B. Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J. Biol. Chem. 1998, 273:30879-30887.
38. Pfister S.L., Spitzbarth N., Zeldin D.C., Lafite P., Mansuy D., Campbell W.B. Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450. Arch. Biochem. Biophys. 2003, 420:142-152.
39. Plane F., Wiley K.E., Jeremy J.Y., Cohen R.A., Garland C.J. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery. Br. J. Pharmacol. 1998, 123:1351-1358.
40. Santhanam L., Lim H.K., Miriel V., Brown T., Patel M., Balanson S., Ryoo S., Anderson M., Irani K., Khanday F., Di Costanzo L., Nyhan D., Hare J.M., Christianson D.W., Rivers R., Shoukas A., Berkowitz D.E. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 2007, 101:692-702.
41. Schnurr K., Belkner J., Ursini F., Schewe T., Kuhn H. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products. J. Biol. Chem. 1996, 271:4653-4658.
42. Singer H.A., Peach M.J. Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid. J. Pharmacol. Exp. Ther. 1983, 226:790-795.
43. Stokes K.Y., Cooper D., Tailor A., Granger D.N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic. Biol. Med. 2002, 33:1026-1036.
44. Tang X., Holmes B.B., Nithipatikom K., Hillard C.J., Kuhn H., Campbell W.B. Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta. Arterioscler. Thromb. Vasc. Biol. 2006, 26:78-84.
45. Tang X., Aggarwal N., Holmes B.B., Kuhn H., Campbell W.B. Age-related decrease in 15-lipoxygenase contributes to reduced vasorelaxation in rabbit aorta. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H679-H687.
46. Tang Z., Yang J., Liu X., Wang Y., Peng S. Polyaspartoyl.l-arginine enhances prostacyclin synthesis in rat aortic endothelial cells. Eur. J. Pharmacol. 2008, 601:124-128.
47. Viita H., Markkanen J., Eriksson E., Nurminen M., Kinnunen K., Babu M., Heikura T., Turpeinen S., Laidinen S., Takalo T., Yla-Herttuala S. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ. Res. 2008, 102:177-184.
48. Weisbrod R.M., Griswold M.C., Yaghoubi M., Komalavilas P., Lincoln T.M., Cohen R.A. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Br. J. Pharmacol. 1998, 125:1695-1707.
49. Ye H., Bi H.R., Lu C.L., Tang X.B., Zhu D.L. 15-hydroxyeicosatetraenoic acid depressed endothelial nitric oxide synthase activity in pulmonary artery. Sheng Li Xue Bao 2005, 57:612-618.
50. Zagryazhskaya A.N., Lindner S.C., Grishina Z.V., Galkina S.I., Steinhilber D., Sud'ina G.F. Nitric oxide mediates distinct effects of various LPS chemotypes on phagocytosis and leukotriene synthesis in human neutrophils. Int. J. Biochem. Cell Biol. 2010, 42:921-931.
51. +. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H152-H159.